Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Metabolic therapeutics therapeutics Market Research Reports

Titlepublishedprice

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H2 2017

By Global Markets Direct
"...... mal storage disorder caused by a deficiency of alpha-L-iduronidase, a lysosomal enzyme normally required for the breakdown of certain complex carbohydrates known as glycosaminoglycans (GAGs). Symptoms include abnormal bones in the spine, claw hand, c......"
29-Dec-2017$2000

Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) - Pipeline Review, H2 2017

By Global Markets Direct
"...... s Hunter syndrome, is a condition that affects many different parts of the body and occurs almost exclusively in males. Signs and symptoms include claw-like hands, protruding tongue, changing facial features, including thickening of the lips, tongue ......"
29-Dec-2017$2000

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H2 2017

By Global Markets Direct
"...... wn as Sanfilippo syndrome, is an inherited metabolic disease caused by an absence or malfunctioning of certain enzymes needed to breakdown molecules called glycosaminoglycans (GAG). Symptoms include seizures, hyperactivity, liver and spleen enlargeme......"
29-Dec-2017$2000

Hyperinsulinemia - Pipeline Review, H2 2017

By Global Markets Direct
"...... insulin circulating in the blood relative to the level of glucose. Insulin resistance is the primary cause of hyperinsulinemia. Symptoms include weight gain, feeling anxious, fatigue and frequently hungry. Risk factors include higher triglyceride lev......"
29-Dec-2017$2000

Fabry Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... t details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for Fabry Disease which can turn out to be future prospective competitors for the marketed......"
01-Nov-2017$1500

Fabry Disease - Epidemiology Forecast to 2025

By Delve Insight
"...... t also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Insulin Resistance. The report contains the targeted patient populations and the forecast methodology. Th......"
01-Nov-2017$2950

Fabry Disease - Pipeline Insight, 2017

By Delve Insight
"...... rt provides information on the therapeutic development for Fabry Disease, dealing with all the pipeline drugs and comparative analysis at various stages covering all clinical, pre-clinical as well as discovery products. The report further contains de......"
01-Nov-2017$1500

Fabry Disease - Market Insights, Epidemiology and Market Forecast - 2025

By Delve Insight
"...... s report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Fabry Disease . It enables understanding of the historical and forecasted epidemiological data for the di......"
01-Nov-2017$5750

Global Lysosomal Storage Disease Partnering 2010-2017

By Current Partnering
"...... panies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering......"
01-Nov-2017$1495

Global Metabolic Partnering 2010-2017: Deal trends, players and financials

By Current Partnering
"...... tabolic partnering deals Financial deal terms for headline, upfront and royalty by stage of development Metabolic partnering agreement structure Metabolic partnering contract documents Top Metabolic deals by value M......"
01-Nov-2017$2995